JPH04506216A
(ja)
*
|
1989-06-13 |
1992-10-29 |
アボツト・ラボラトリーズ |
薬物送達用の油を主成分とした非水性液体懸濁液
|
US5496535A
(en)
*
|
1991-04-12 |
1996-03-05 |
Alliance Pharmaceutical Corp. |
Fluorocarbon contrast media for use with MRI and radiographic imaging
|
DE4200821A1
(de)
*
|
1992-01-15 |
1993-07-22 |
Bayer Ag |
Geschmacksmaskierte pharmazeutische mittel
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5997904A
(en)
*
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
DK0693924T4
(da)
*
|
1993-02-22 |
2008-08-04 |
Abraxis Bioscience Inc |
Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5567592A
(en)
*
|
1994-02-02 |
1996-10-22 |
Regents Of The University Of California |
Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
|
EP0758549A4
(en)
*
|
1994-04-26 |
1997-07-02 |
Nobuhiro Narita |
MEDICAL COMPOSITION AS A MEDICINE FOR NON-SMALL CELL CANCER
|
US5484800A
(en)
*
|
1994-08-30 |
1996-01-16 |
American Home Products Corporation |
Lipid-based liquid medicinal composition
|
SI9400338A
(en)
*
|
1994-08-31 |
1996-04-30 |
Lek D D |
Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
|
US5665386A
(en)
*
|
1995-06-07 |
1997-09-09 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
US5716928A
(en)
*
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
JPH11507356A
(ja)
*
|
1995-06-07 |
1999-06-29 |
アブマックス,インコーポレイティド |
経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用
|
AUPN605795A0
(en)
*
|
1995-10-19 |
1995-11-09 |
F.H. Faulding & Co. Limited |
Analgesic pharmaceutical composition
|
US6949264B1
(en)
|
1996-11-27 |
2005-09-27 |
Wm. Wrigley Jr. Company |
Nutraceuticals or nutritional supplements and method of making
|
US6180666B1
(en)
|
1997-09-05 |
2001-01-30 |
Anmax, Inc. |
Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
|
US5962522A
(en)
*
|
1997-09-05 |
1999-10-05 |
Avmax, Inc. |
Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
|
BR9705470A
(pt)
*
|
1997-11-12 |
1999-07-06 |
Ind Quimica E Farmaceutica Sch |
Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
|
US6627234B1
(en)
|
1998-12-15 |
2003-09-30 |
Wm. Wrigley Jr. Company |
Method of producing active agent coated chewing gum products
|
US7163705B2
(en)
|
1998-12-15 |
2007-01-16 |
Wm. Wrigley Jr. Company |
Coated chewing gum product and method of making
|
US6586023B1
(en)
|
1998-12-15 |
2003-07-01 |
Wm. Wrigley Jr. Company |
Process for controlling release of active agents from a chewing gum coating and product thereof
|
US6531114B1
(en)
|
1999-04-06 |
2003-03-11 |
Wm. Wrigley Jr. Company |
Sildenafil citrate chewing gum formulations and methods of using the same
|
US6846495B2
(en)
|
1999-01-11 |
2005-01-25 |
The Procter & Gamble Company |
Compositions having improved delivery of actives
|
US7935362B2
(en)
|
1999-04-06 |
2011-05-03 |
Wm. Wrigley Jr. Company |
Over-coated product including consumable center and medicament
|
US6355265B1
(en)
|
1999-04-06 |
2002-03-12 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US6773716B2
(en)
|
1999-04-06 |
2004-08-10 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US6322806B1
(en)
|
1999-04-06 |
2001-11-27 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations including tableted center
|
US6645535B2
(en)
|
1999-09-02 |
2003-11-11 |
Wm. Wrigley Jr. Company |
Method of making coated chewing gum products containing various antacids
|
US6663849B1
(en)
|
2000-09-01 |
2003-12-16 |
Wm. Wrigley Jr. Company |
Antacid chewing gum products coated with high viscosity materials
|
US6569472B1
(en)
|
2000-09-01 |
2003-05-27 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing antacid and method of making
|
US6541048B2
(en)
|
1999-09-02 |
2003-04-01 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an acid blocker and process of preparing
|
US9253991B2
(en)
|
1999-09-20 |
2016-02-09 |
Jack Barreca |
Chewing gum with B vitamins
|
WO2001021147A1
(en)
|
1999-09-20 |
2001-03-29 |
Mastercare |
Diet and weight control gum and sucker
|
US9387168B2
(en)
|
1999-09-20 |
2016-07-12 |
Jack Barreca |
Chewing gum with tomatidine
|
US6572900B1
(en)
|
2000-06-09 |
2003-06-03 |
Wm. Wrigley, Jr. Company |
Method for making coated chewing gum products including a high-intensity sweetener
|
US7115288B2
(en)
|
2000-06-09 |
2006-10-03 |
Wm. Wrigley Jr. Company |
Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
|
US6444241B1
(en)
|
2000-08-30 |
2002-09-03 |
Wm. Wrigley Jr. Company |
Caffeine coated chewing gum product and process of making
|
US6919370B2
(en)
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
US6579545B2
(en)
|
2000-12-22 |
2003-06-17 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an antigas agent
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
AU2003245504A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
US20040202696A1
(en)
*
|
2003-04-14 |
2004-10-14 |
Cts Chemical Industries Ltd. |
Administration form for veterinary use
|
GB0308732D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
GB0308734D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
EP1638529B1
(en)
*
|
2003-06-16 |
2016-08-10 |
ANDRX Pharmaceuticals, LLC. |
Oral extended-release composition
|
WO2011107855A2
(en)
|
2010-03-04 |
2011-09-09 |
Torrent Pharmaceuticals Limited |
Sustained release oral liquid suspension dosage form
|
FR3000400B1
(fr)
*
|
2012-12-27 |
2019-06-21 |
Virbac |
Suspension huileuse de metronidazole
|
US20170326161A1
(en)
*
|
2015-12-10 |
2017-11-16 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
|